OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic regulation of insulin action and secretion – role in the pathogenesis of type 2 diabetes
Charlotte Ling
Journal of Internal Medicine (2020) Vol. 288, Iss. 2, pp. 158-167
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 411

DNA methylation levels may contribute to severe hypertriglyceridemia in multifactorial chylomicronemia syndrome
Simon‐Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Clinical Biochemistry (2025) Vol. 135, pp. 110873-110873
Closed Access | Times Cited: 3

Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
Haruka Tsubaki, Ikuo Tooyama, Douglas G. Walker
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9357-9357
Open Access | Times Cited: 106

Phenolic Bioactives From Plant-Based Foods for Glycemic Control
Dipayan Sarkar, Ashish Christopher, Kalidas Shetty
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 40

Restoring Epigenetic Reprogramming with Diet and Exercise to Improve Health-Related Metabolic Diseases
Merlin Jesso Abraham, Adham El Sherbini, Mohammad El‐Diasty, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 20

Thioredoxin-Interacting Protein in Cancer and Diabetes
Hiroshi Masutani
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 13-15, pp. 1001-1022
Open Access | Times Cited: 36

Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus
Luis Vitetta, Nick N. Gorgani, Gemma Vitetta, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1307-1307
Open Access | Times Cited: 15

The Active Ingredient Catalpol in Rehmannia glutinosa Reduces Blood Glucose in Diabetic Rats via the AMPK Pathway
Li Yang, Qiang Chen, H.J. Sun, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1761-1767
Open Access | Times Cited: 5

Epigenetics of Hepatic Insulin Resistance
Hannah Maude, Claudia Sanchez-Cabanillas, Inês Cebola
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 32

Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
Karina Ramí­rez-Alarcón, Montserrat Victoriano, Lorena Mardones, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 32

Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis
Shanshan Hu, Xiaorong Su, Guorong Fan
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13

Exploring Public Health Strategies Related to Chronic Diseases: Taking Type 2 Diabetes as an Example
Zechen Pi
Theoretical and Natural Science (2025) Vol. 69, Iss. 1, pp. 183-188
Closed Access

Longitudinal association between DNA methylation and type 2 diabetes: findings from the KORA F4/FF4 study
Liye Lai, Dave Laurence Juntilla, M Shad Del, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access

Metabolic dysfunction and insulin sensitizers in acute and chronic disease
Jerry R. Colca, Kyle S. McCommis
Expert Opinion on Investigational Drugs (2025), pp. 1-10
Closed Access

Association of KCNJ11 E23K/rs5219 Gene Polymorphism with Type 2 Diabetes and Diabetes-Related Cardiovascular Disease
Monika Buraczyńska, Sylwia Boczkowska, Wojciech Załuska
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 653-661
Open Access

Advancements in the study of DLK1 in the pathogenesis of diabetes
Min Li, Yanqiu Peng, Yuke Shi, et al.
Life Sciences (2025) Vol. 369, pp. 123535-123535
Closed Access

RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access

Antidiabetic Activity of Momordica charantia Extracts Through Incretin Pathway in Streptozotocin-Nicotinamide Induced Diabetic Rat Depends on Dose Differences
Muhammad Fadhol Romdhoni, Muchsin Doewes, Soetrisno Soetrisno, et al.
Avicenna Journal of Medical Biotechnology (2025)
Closed Access

Assessment of the Risk of Insulin Resistance in Workers Classified as Metabolically Healthy Obese
Miguel García Samuelsson, Pedro Juan Tárraga López, Ángel Arturo López‐González, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1345-1345
Open Access

Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention
Rout George Kerry, Gyana Prakash Mahapatra, Ganesh Kumar Maurya, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 2, pp. 421-451
Closed Access | Times Cited: 27

Lipid Phenotypes and DNA Methylation: a Review of the Literature
Alana Jones, Marguerite R. Irvin, Steven A. Claas, et al.
Current Atherosclerosis Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 22

Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity
Emma K. Rautenberg, Yassin Hamzaoui, Dawn K. Coletta
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 15

Comparison of genetic and epigenetic profiles of periodontitis according to the presence of type 2 diabetes
Junho Kang, Hansong Lee, Ji‐Young Joo, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top